| HTx Patients Transplanted between Mar.-Sep. 2020 (n=55) | HTx Patients Transplanted between Mar.-Sept. 2017–2019 (n=169) | P-Value | |
|---|---|---|---|
| 6-Month Survival | 92.7% | 94.1% | 0.733 |
| 6-Month Freedom from ATR | 90.9% | 91.1% | 0.981 |
| Rehospitalization within 6 Months | 16.4% (9) | 37.9% (64) | 0.003 |
| Non-COVID Infection within 6 Months | 10.9% (6) | 18.9% (32) | 0.323 |